A novel CYR61/ER connection is regulates anti-estrogen resistance in breast cancer.

被引：0
|
作者：
Espinoza, I
Rasor, G.
Liu, H.
Lupu, R.
机构：
[1] Evanston NW Healthcare Res Inst, Evanston, IL USA
[2] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2006年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [41] CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer
    Kim, Hyungjoo
    Son, Seogho
    Ko, Yunhyo
    Lim, Hogeun
    Lee, Joohyung
    Lee, Kyung-Min
    Shin, Incheol
    CARCINOGENESIS, 2024, 45 (07) : 510 - 519
  • [42] Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies
    Tsai, MS
    Hornby, AE
    Lakins, J
    Lupu, R
    CANCER RESEARCH, 2000, 60 (20) : 5603 - 5607
  • [43] CYR61 Expression Promotes Taxol Resistance: A Molecular Link with the p53 in Breast.
    Espinoza, I
    Lupu, R.
    CANCER RESEARCH, 2009, 69 (24) : 583S - 583S
  • [44] CYR61, a member of the CCN protein family, regulates IGF-1 in metastatic prostate cancer
    Ortiz-Hernandez, Greisha L.
    Walker, Mya
    Woods-Burnham, Leanne
    Kittles, Rick A.
    Casiano, Carlos A.
    Neuhausen, Susan L.
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Increased vascularity and spontaneous metastasis of breast cancer by hedgehog signaling mediated upregulation of cyr61
    Harris, L. G.
    Pannell, L. K.
    Singh, S.
    Samant, R. S.
    Shevde, L. A.
    ONCOGENE, 2012, 31 (28) : 3370 - 3380
  • [46] Pathologic Changes in Breast Cancer After Anti-Estrogen Therapy
    Samarnthai, Norasate
    Elledge, Richard
    Prihoda, Thomas J.
    Huang, Jian
    Massarweh, Suleiman
    Yeh, I-Tien
    BREAST JOURNAL, 2012, 18 (04): : 362 - 366
  • [47] Pathologic changes in breast cancer after anti-estrogen therapy
    Samarnthai, Norasate
    Elledge, Richard
    Huang, Jian
    Massarweh, Suleiman
    Yeh, I-Tien
    FASEB JOURNAL, 2010, 24
  • [48] Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer
    Chen, Xiaofeng
    Zha, Xiaoming
    Chen, Wei
    Zhu, Tingting
    Qiu, Jinrong
    Roe, Oluf Dimitri
    Li, Jun
    Wang, Zhaoxia
    Yin, Yongmei
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (01) : 22 - 30
  • [49] Un"Abl"ing Anti-estrogen Therapy Resistance in Estrogen Receptor-alpha Positive Breast Cancer
    Cook, K. L.
    Schwartz, J. L.
    Facey, C. O. B.
    Jin, L.
    Zwart, A.
    Abu-Azab, M.
    Warri, A.
    Clarke, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 26 - 26
  • [50] Selective recruitment of breast cancer anti-estrogen resistance genes and relevance for breast cancer progression and tamoxifen therapy response
    van Agthoven, Ton
    Sieuwerts, Anieta M.
    Meijer, Danielle
    Meijer-van Gelder, Marion E.
    van Agthoven, Thecla L. A.
    Sarwari, Roya
    Sleijfer, Stefan
    Foekens, John A.
    Dorssers, Lambert C. J.
    ENDOCRINE-RELATED CANCER, 2010, 17 (01) : 215 - 230
12345